Headstrong Intervention for Recurrent Pediatric Headache

顽固干预治疗复发性小儿头痛

基本信息

项目摘要

DESCRIPTION (provided by applicant): Recurrent pediatric headache is a chronic pain syndrome affecting more than two million American children and often resulting in significant functional disability and debilitation. Moreover, this syndrome represents a substantial cost to the patient's family and the health care system. The goal of the present study is to evaluate the efficacy of a new cost-effective approach to the treatment of recurrent pediatric headache that allows children to learn how to self-manage their headaches via a CD-ROM program (called "Headstrong TM"). This grant proposal is being submitted in response to PA-01-115, which called for research seeking to identify and refine innovative and effective treatment strategies for specific pain conditions. A randomized trial will be used to evaluate the effectiveness of the Headstrong TM intervention. One-hundred and eight (108) pediatric patients, ages 7-12 years, with a diagnosed recurrent migraine, muscle-contraction, or chronic daily headache syndrome will be enrolled in the study. After enrollment, each patient's baseline headache frequency, duration, and intensity will be assessed for one month using headache diaries. During this one-month baseline period, we will also collect data to examine headache-related disability and health related quality of life. After baseline, patients will be randomly assigned to the standard medical care plus Headstrong TM intervention or the standard medical care plus Education condition (also a CD-ROM program with information about recurrent headaches, such as types, etiology, and triggers). Both groups will work through modules in their respective programs over the course of one month. Dependent measures will then continue to be collected at one-month post-treatment and three-, six-, and twelve-month post-treatment follow-up. The primary study outcome will be headache frequency, duration, and intensity as measured by daily headache diaries. Secondary endpoints will include headache-related disability outcomes and quality of life.
描述(由申请人提供):复发性儿童头痛是一种慢性疼痛综合征,影响着200多万美国儿童,经常导致严重的功能残疾和虚弱。此外,这种综合征给患者的家庭和卫生保健系统带来了巨大的成本。本研究的目的是评估一种新的具有成本效益的方法治疗复发性儿童头痛的有效性,该方法允许儿童学习如何通过CD-ROM计划(称为“Headstrong TM”)自我管理他们的头痛。这项赠款提案是对PA-01-115的响应,PA-01-115呼吁进行研究,寻求确定和完善针对特定疼痛状况的创新和有效的治疗策略。一项随机试验将用于评估Headstrong TM干预的有效性。108名儿童患者,年龄7-12岁,被诊断为复发性偏头痛、肌肉收缩或慢性日常头痛综合征,将被纳入研究。登记后,每个患者的基线头痛频率、持续时间和强度将使用头痛日记进行为期一个月的评估。在这一个月的基线期间,我们还将收集数据,以检查与头痛相关的残疾和与健康相关的生活质量。在基线之后,患者将被随机分配到标准医疗护理+Headstrong TM干预或标准医疗护理+教育条件(也是一个光盘计划,其中包含有关反复头痛的信息,如类型、病因和触发因素)。这两个小组将在一个月的时间里完成各自计划中的模块。然后将在治疗后一个月以及治疗后三个月、六个月和十二个月的随访中继续收集依赖措施。主要研究结果将是头痛的频率、持续时间和强度,通过每天的头痛日记来衡量。次要终点将包括与头痛相关的残疾结果和生活质量。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MICHAEL Andrew RAPOFF其他文献

MICHAEL Andrew RAPOFF的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MICHAEL Andrew RAPOFF', 18)}}的其他基金

Adherence-strong for juvenile arthritis
对幼年关节炎具有很强的依从性
  • 批准号:
    8109194
  • 财政年份:
    2010
  • 资助金额:
    $ 22万
  • 项目类别:
Adherence-strong for juvenile arthritis
对幼年关节炎具有很强的依从性
  • 批准号:
    7989069
  • 财政年份:
    2010
  • 资助金额:
    $ 22万
  • 项目类别:
Jointstrong intervention for juvenile arthritis
幼年关节炎的联合强干预
  • 批准号:
    7468573
  • 财政年份:
    2008
  • 资助金额:
    $ 22万
  • 项目类别:
Jointstrong intervention for juvenile arthritis
幼年关节炎的联合强干预
  • 批准号:
    8038555
  • 财政年份:
    2008
  • 资助金额:
    $ 22万
  • 项目类别:
Jointstrong intervention for juvenile arthritis
幼年关节炎的联合强干预
  • 批准号:
    7599595
  • 财政年份:
    2008
  • 资助金额:
    $ 22万
  • 项目类别:
Headstrong Intervention for Recurrent Pediatric Headache
顽固干预治疗复发性小儿头痛
  • 批准号:
    7586519
  • 财政年份:
    2004
  • 资助金额:
    $ 22万
  • 项目类别:
Headstrong Intervention for Recurrent Pediatric Headache
顽固干预治疗复发性小儿头痛
  • 批准号:
    7124466
  • 财政年份:
    2004
  • 资助金额:
    $ 22万
  • 项目类别:
Headstrong Intervention for Recurrent Pediatric Headache
顽固干预治疗复发性小儿头痛
  • 批准号:
    7100280
  • 财政年份:
    2004
  • 资助金额:
    $ 22万
  • 项目类别:
ADHERENCE TO INHALED CORTICOSTEROIDS IN CHILDHOOD ASTHMA
儿童哮喘患者坚持吸入皮质类固醇
  • 批准号:
    6343191
  • 财政年份:
    1999
  • 资助金额:
    $ 22万
  • 项目类别:
ADHERENCE TO INHALED CORTICOSTEROIDS IN CHILDHOOD ASTHMA
儿童哮喘患者坚持吸入皮质类固醇
  • 批准号:
    6138801
  • 财政年份:
    1999
  • 资助金额:
    $ 22万
  • 项目类别:

相似海外基金

Unravelling the neural basis of breathing, respiratory depression, and analgesia by opioid drugs.
揭示阿片类药物呼吸、呼吸抑制和镇痛的神经基础。
  • 批准号:
    479039
  • 财政年份:
    2023
  • 资助金额:
    $ 22万
  • 项目类别:
    Operating Grants
Dissociating respiratory depression and analgesia via a data-driven model of interacting respiratory and pain networks
通过呼吸和疼痛网络相互作用的数据驱动模型分离呼吸抑制和镇痛
  • 批准号:
    10644300
  • 财政年份:
    2023
  • 资助金额:
    $ 22万
  • 项目类别:
Elucidating causal mechanisms of ethanol-induced analgesia in BXD recombinant inbred mouse lines
阐明 BXD 重组近交系小鼠乙醇诱导镇痛的因果机制
  • 批准号:
    10825737
  • 财政年份:
    2023
  • 资助金额:
    $ 22万
  • 项目类别:
Identification of allosteric molecules for DOR-KOR heteromer-mediated peripheral analgesia
DOR-KOR 异聚体介导的外周镇痛变构分子的鉴定
  • 批准号:
    10608439
  • 财政年份:
    2023
  • 资助金额:
    $ 22万
  • 项目类别:
Evaluation of the Role of Macrophage Migratory Inhibitory Factor (MIF) in mediating Stem Cell Analgesia in a Model of Orofacial Pain
评估巨噬细胞迁移抑制因子(MIF)在口面部疼痛模型中介导干细胞镇痛的作用
  • 批准号:
    10585412
  • 财政年份:
    2023
  • 资助金额:
    $ 22万
  • 项目类别:
Psilocybin for Enhanced Analgesia in Chronic nEuropathic PAIN (PEACE-PAIN) Study: A Pilot Randomized Controlled Trial
裸盖菇素用于增强慢性神经病性疼痛 (PEACE-PAIN) 镇痛效果的研究:一项随机对照试验
  • 批准号:
    479442
  • 财政年份:
    2023
  • 资助金额:
    $ 22万
  • 项目类别:
    Operating Grants
Development of a regional anesthesia guidance system to increase patient access to opioid-sparing analgesia for hip fracture pain
开发区域麻醉引导系统,以增加患者获得髋部骨折疼痛的阿片类药物保留镇痛的机会
  • 批准号:
    10759550
  • 财政年份:
    2023
  • 资助金额:
    $ 22万
  • 项目类别:
Maintaining opioid analgesia and preventing addiction with hypocretin antagonism
通过下丘脑分泌素拮抗作用维持阿片类药物镇痛并预防成瘾
  • 批准号:
    10713175
  • 财政年份:
    2023
  • 资助金额:
    $ 22万
  • 项目类别:
Accounting for selection and information bias in studies of Autism Spectrum Disorder
自闭症谱系障碍研究中的选择和信息偏差的解释
  • 批准号:
    10677370
  • 财政年份:
    2023
  • 资助金额:
    $ 22万
  • 项目类别:
Developing a potent non-addictive analgesic as an alternative to conventional opioids
开发一种有效的非成瘾性镇痛药作为传统阿片类药物的替代品
  • 批准号:
    479782
  • 财政年份:
    2023
  • 资助金额:
    $ 22万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了